These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 108706)

  • 1. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
    Mueller RA; Towle A; Breese GR
    Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide.
    Sperk G; Stewart RM; Campbell A; Baldessarini RJ
    Brain Res; 1978 Dec; 159(1):183-94. PubMed ID: 310331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
    Warbritton JD; Stewart RM; Baldessarini RJ
    Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 8. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
    Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
    Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5,7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 Jun; 20(6):611-6. PubMed ID: 6972494
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in motor behavior following the administration of serotonin neurotoxins.
    Growdon JH
    Ann N Y Acad Sci; 1978 Jun; 305():510-23. PubMed ID: 309302
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
    Pranzatelli MR; Dollison AM; Hlibczuk V
    Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-5-Hydroxytryptophan-induced flat body posture in the rat: antagonism by ritanserin and potentiation after 5,7-dihydroxytryptamine.
    Colpaert FC; Koek W; Lategan A
    Eur J Pharmacol; 1989 Oct; 169(1):175-8. PubMed ID: 2513211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.
    Ortmann R; Martin S; Waldmeier PC
    Psychopharmacology (Berl); 1981; 74(2):109-14. PubMed ID: 6115443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats.
    Breese GR; Mueller RA
    Ann N Y Acad Sci; 1978 Jun; 305():160-74. PubMed ID: 280248
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
    Pranzatelli MR; Snodgrass SR
    Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
    Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
    Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
    Saller CF; Stricker EM
    Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.